𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer

✍ Scribed by Sang Joon Shin; Joong Bae Ahn; Hye Jin Choi; Byoung Chul Cho; Hei-Cheul Jeung; Sun Young Rha; Hyun Cheol Chung; Jae Kyung Roh

Publisher
Springer
Year
2007
Tongue
English
Weight
311 KB
Volume
61
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Capecitabine plus oxaliplatin (XELOX) ve
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; GΓ©rard Lledo; Thier πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF